Paediatric FH

5th EAS Paediatric Familial Hypercholesterolemia symposium

21st of May 2022, Milan, Italy

This event will take place in the Starhotels ECHO Hotel (Viale Andrea Doria, 4, 20124 Milano MI, Italy) 

Register for FREE here

Registration will close on May 19, 2022

Organized by: Cristina Pederiva, Jeanine Roeters van Lennep, Nathalie Brun, Mafalda Bourbon, Michal Vrablik and Steve Humphries


10.00-10.05 Welcome – Steve Humphries and Cristina Pederiva

10.05 – 11.20 Topic 1 – How concerned should we be about high Lp(a) in children as a future CHD risk factor?

Chairs: Alpo Vuorio (Finland) and Ornella Guardamagna (Italy)

10-05-10.25. Lp(a): How to measure it? Jai Cegla (UK)

10.25-10.45. LDL-cholesterol goal achievement, cardiovascular disease, and attributed risk of Lp(a) in a large cohort of predominantly genetically verified familial hypercholesterolemia. Martin Bogsrud (Norway)

10.45-10.55. Presentation of  a patient with high Lp(a) perhaps a video of an interview Magdalena Daccord (FH  Europe)

10.55-11.10. Familial hypercholesterolemia and elevated lipoprotein(a): double heritable risk and new therapeutic opportunities. Alpo Vuorio (Finland)

11.10-11.20. Clinical Scenarios relating to Lp(a)

11.20-11.45 Coffee

11.45- 13.00 Topic 2 – Do imaging technologies for assessing atherosclerosis presence and progression in children have clinical utility?  Chairs: Albert Wiegman (Holland) and Jeanine Roeters van Lennep (The Netherlands)

11.45-12.00. The clinical utility of CIMT in determining the management of children with Heterozygous FH – Albert Wiegman (The Netherlands) 

12.00-12.15. The clinical utility of CTA in determining treatment effects in children with Homozygous FH (if possible evinacumab paediatric trial data) – Doortje Reijman (The Netherlands) 

12.15-12.30 Effect of lomitapide on CIMT in children with homozygous FH  Dirk Blom (South Africa)

13.00-14.00 Lunch

14.00-15.50 Topic 3 : Hyperlipidaemia in children: limits of screening programs, management of border-line lipid levels
Chairs: Michal Vrablik  (CR) and Cristina Pederiva (Italy)

14.00-14.20. FH screening in children: best practice and state of the art – Urh Grošelj (Slovenia)

14.20-14.40. Borderline high LDL-C levels identified through screening: algorithm for treatment and patient pathway description-Cristina Pederiva (Italy)

14.40-15.00. Elevated LDL-C levels: when is genetic testing indicated-Tom Freiberger (Czech Republic)

15.00-15.20. Long term follow-up of children with familial hypercholesterolemia and relatively normal LDL-cholesterol at diagnosis. – Kirsten Bjørklund Holven (Norway)

15.20- 15.40. High TGs in FH children, alert levels and best treatment Maria Elena Capra (Italy)

15.50-16.00 Voting for next year’s topics and Wrap up

16.00-16.45 Closing networking drink

We are pleased to announce that funding has been obtained by FH Europe to allow the symposium proceedings to be recorded. All registered delegates will receive information on how to access the proceedings after the symposium.

*The symposium is free of charge for all delegates. Please note that a no-show fee of €100 will be charged if you cancel your participation later than Friday 13 May or do not show up at the symposium.